The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 76.00
Bid: 60.00
Ask: 75.00
Change: 6.00 (8.57%)
Spread: 15.00 (25.00%)
Open: 70.00
High: 76.00
Low: 67.50
Prev. Close: 70.00
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Biome receives £282k grant

16 Nov 2022 07:00

RNS Number : 5289G
Biome Technologies PLC
16 November 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

 

16 November 2022

 

Biome Technologies plc

 

("Biome", "the Company" or "the Group")

 

Biome receives £282k grant to scale-up novel biopolymers

 

Biome announces that its Bioplastics division (www.biomebioplastics.com) has been awarded £282,000 in funding from Innovate UK, the UK Government's innovation agency, to support the scale-up of novel compostable biopolymers for the flexible packaging and coatings industries in collaboration with Thomas Swan (www.thomas-swan.co.uk) and the University of Nottingham. The project has a total investment of £474,000 and is expected to last 18 months.

Over the last nine years, Biome has undertaken considerable research and development work on a range of biodegradable polymers, based on bio-based inputs. This work has involved seven universities and around 30 leading scientists and engineers. All the resultant polymers are subject to patent protection or patent application. Before this new Innovate UK grant, these novel polymers have only been scaled successfully from laboratory test-tube to small kilogram quantities on pilot plant equipment.

 

The new funding for this project will scale up one of these promising polymers to quantities of hundreds of kilograms on Thomas Swan's industrial-scale assets. This selected polymer is based on furan dicarboxylic acid (FDCA), an important new bio-based chemical. Such production will allow the performance and production process of this polymer to be evaluated at a commercially relevant scale.

 

Thomas Swan is a leading independent manufacturer of performance and fine chemicals with offices in the United States and China and a global network of distributors. The company manufactures over 100 products, from kilogram to multi-tonne quantities, and offers an experienced and flexible custom manufacturing service. Thomas Swan has collaborated with Biome's development for the last few years and is well-placed to support this specific project and ultimately manufacture Biome's novel FDCA based polymers at a commercial scale.

 

The University of Nottingham has worked with Biome for the past five years. Its contribution to this project will be led by Derek Irvine, Professor of Materials Chemistry at the institution's Faculty of Engineering. His team will support the technology transfer from the laboratory to Thomas Swan and work on further enhancements to the FDCA-derived polymer.

 

This work forms part of Biome's approach to providing highly functional added-value products to the market. It is envisaged that products derived from this collaboration will be commercialised after project completion.

 

Paul Mines, Biome Technologies' Chief Executive, commented:

 

"After nine years of significant work by Biome's scientists, engineers and supporting partners, it is great to be taking a substantial step towards industrialisation in bringing these FDCA-based polymers to the market. Thomas Swan and the University of Nottingham are great partners to support us on our journey to commercialise this new generation of bio-based and compostable polymers."

 

Harry Swan, Thomas Swan's Chief Executive and Owner, added:

 

"This is an excellent project that will see the acceleration of an important new sustainable product for Biome. It also sits well with Thomas Swan's own mission to inspire and deliver sustainable chemistry. Innovate UK grants are not easy to secure which lends great credibility to the technology and its potential. I look forward to seeing this exciting project progress with our partners, Biome and the University of Nottingham."

 

-Ends-

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Rob Smith, Chief Financial Officer

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Sales and Corporate Broking)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited ("Bioplastic") and Stanelco RF Technologies Limited ("RF Technologies").

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil- based polymers.

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

www.biometechnologiesplc.com www.biomebioplastics.com and www.thinkbioplastic.com www.stanelcorftechnologies.com

 

About Thomas Swan

Thomas Swan & Co. Ltd. is an independent chemical manufacturing company. With offices and warehousing in the UK, USA and China and a global network of distributors, they service the domestic and international markets and export to over 80 countries worldwide.

Founded in 1926 in Consett, in the North East of England - still home to their manufacturing facilities - Thomas Swan today produces over 100 products, in kilogramme to multi-tonne quantities, and offers an experienced and flexible manufacturing service.

www.thomas-swan.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFELLFLFLZFBQ
Date   Source Headline
16th Oct 20063:17 pmRNSNotifiable Interest
12th Oct 200612:35 pmRNSDoc re. Posting of Prospectus
11th Oct 20061:09 pmRNSNotifiable Interest
9th Oct 200611:13 amRNSProposed Placing & Open Offer
5th Oct 200610:25 amRNSFinancing Update
3rd Oct 200612:56 pmRNSStatement re. Press Comment
2nd Oct 20064:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20064:35 pmRNSPrice Monitoring Extension
8th Sep 20067:01 amRNSTrading Statement
17th Aug 20067:44 amRNSTrading Statement
16th Aug 20065:52 pmRNSAdditional Listing - AMEND
14th Aug 200611:55 amRNSAdditional Listing
10th Aug 200612:25 pmRNSRe Contract
14th Jul 20067:56 amRNSInterim Results - Replacement
14th Jul 20067:00 amRNSInterim Results
2nd Jun 200611:26 amRNSNew Ord Share Placing-Amendmt
2nd Jun 20068:45 amRNSNew Ordinary Share Placing
25th May 20067:02 amRNSWrap 100 FDA approval
16th May 200610:43 amRNSAdditional Listing
15th May 20067:01 amRNSAppointment of Adviser
3rd May 20061:05 pmRNSNotifiable Interest
2nd May 20064:58 pmRNSResult of AGM
2nd May 20062:00 pmRNSAGM Statement
10th Apr 20063:12 pmRNSAnnual Report and Accounts
7th Apr 20062:46 pmRNSAdditional Listing
13th Mar 20067:02 amRNSDirectorate Change
28th Feb 20067:02 amRNSPreliminary Results
24th Feb 20067:02 amRNSCooperation with Wal-Mart
14th Feb 20069:07 amRNSAdditional Listing
14th Feb 20067:00 amRNSUS FDA approval for Starpol
9th Feb 200610:42 amRNSIsraCaps new licence terms
9th Feb 20067:02 amRNSRe: BioProgress plc
16th Dec 20057:01 amRNSFunding for R&D facility
16th Dec 20057:01 amRNSPre Close Update
14th Dec 20057:01 amRNSLandmark deal with Perseco
8th Dec 200510:25 amRNSShare Listing Application
30th Nov 20055:40 pmRNSDirectorate Change
28th Nov 20059:24 amRNSBoard Changes
8th Nov 20057:01 amRNSPatent sale process update
3rd Nov 20054:47 pmRNSExercise of Options
1st Nov 20057:02 amRNSChange of Adviser
12th Oct 20057:00 amRNSApproval of Starpol
3rd Oct 20057:00 amRNSPatent Disposal & Update
22nd Sep 20057:02 amRNSRe Agreement
12th Sep 20057:03 amRNSDevelopment of capsule
5th Sep 20057:03 amRNSRe: Completion
30th Aug 20053:30 pmRNSDoc re. Result of EGM
30th Aug 200511:08 amRNSEGM Statement
30th Aug 20057:03 amRNSRe Agreement
5th Aug 200511:15 amRNSRe posting of circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.